Toggle navigation
Our Platform
Our Platform
Peptide Receptor Radionuclide Therapy
Peptide-Drug Conjugate Program
SOR-C13 TRPV6 Inhibitor
Science
Discovery
The Target: TRPV6
Mechanism of Action
Intellectual Property
About
Our Team
For Investors
News and Events
Resources
Contact
CLOSE
Toggle navigation
Our Platform
Our Platform
Peptide Receptor Radionuclide Therapy
Peptide-Drug Conjugate Program
SOR-C13 TRPV6 Inhibitor
Science
Discovery
The Target: TRPV6
Mechanism of Action
Intellectual Property
About
Our Team
For Investors
News and Events
Resources
Contact
November 26, 2019
TRPV6 as A Target for Cancer Therapy
Click to view PDF
Sign up to receive updates from Soricimed
Submit
Powered by Innovasium
